PCR-based diagnosis is not always useful in the acute acquired toxoplasmosis in immunocompetent individuals.


Journal

Parasitology research
ISSN: 1432-1955
Titre abrégé: Parasitol Res
Pays: Germany
ID NLM: 8703571

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 28 03 2020
accepted: 14 12 2020
pubmed: 9 1 2021
medline: 16 4 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

Toxoplasmosis is the most prevalent zoonosis in the world and is associated with a large spectrum of diseases. Acute acquired toxoplasmosis (AAT) is considered a benign and self-limiting disease but severe postnatal infections have been reported, particularly in South America. Laboratory diagnosis is based on the detection of anti-Toxoplasma gondii IgM, IgG, and presence of low IgG avidity. However, these assays present limitations, and therefore, PCR has been suggested as an alternative diagnostic tool. In this study, we performed real-time and nested PCR in DNA blood samples from 59 individuals with AAT lasting less than 80 days. None of the patients had parasitic DNA detected by PCR, even in the more severe cases or when blood was collected early after disease onset. These negative results indicate that the parasitemia kinetics needs investigation to determine the best time for blood sampling, especially in immunocompetent individuals. Thus, we emphasize that a negative PCR result does not exclude recent T. gondii infection, and serological criteria are still decisive for the laboratory diagnosis of AAT.

Identifiants

pubmed: 33415403
doi: 10.1007/s00436-020-07022-6
pii: 10.1007/s00436-020-07022-6
doi:

Substances chimiques

DNA, Protozoan 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-767

Références

Ajzenberg D, Lamaury I, Demar M, Vautrin C, Cabié A, Simon S, Nicolas M, Desbois-Nogard N, Boukhari R, Riahi H, Dardé M-L, Massip P, Dupon M, Preux P-M, Labrunie A, Boncoeur M-P (2016) Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French departments of America and genetic diversity of toxoplasma gondii: a prospective and multicentric study. PLoS Negl Trop Dis 10:e0004790. https://doi.org/10.1371/journal.pntd.0004790
doi: 10.1371/journal.pntd.0004790 pubmed: 27355620 pmcid: 4927177
Belaz S, Gangneux J-P, Dupretz P, Guiguen C, Robert-Gangneux F (2015) A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. J Clin Microbiol 53:1294–1300. https://doi.org/10.1128/JCM.02900-14
doi: 10.1128/JCM.02900-14 pubmed: 25653416 pmcid: 4365238
Brenier-Pinchart M-P, Capderou E, Bertini R-L, Bailly S, Fricker-Hidalgo H, Varlet-Marie E, Murat J-B, Sterkers Y, Touafek F, Bastien P, Pelloux H (2015) Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii. Diagn Microbiol Infect Dis 82:289–291. https://doi.org/10.1016/j.diagmicrobio.2015.04.004
doi: 10.1016/j.diagmicrobio.2015.04.004 pubmed: 25957458
Cermáková Z, Prásil P, Valenta Z, Förstl M, Plísková L, Bolehovská R (2009) Considering the role of the PCR method in routine diagnosis of toxoplasmosis in peripheral blood tests in immunocompetent patients. Klin Mikrobiol Infekcni Lek 15:138–142
Costa JGL, Carneiro ACAV, Tavares AT, Andrade GMQ, Vasconcelos-Santos DV, Januário JN, Menezes-Souza D, Fujiwara RT, Vitor RWA (2013) Real-time PCR as a prognostic tool for human congenital toxoplasmosis. J Clin Microbiol 51:2766–2768. https://doi.org/10.1128/JCM.00982-13
doi: 10.1128/JCM.00982-13 pubmed: 23761154 pmcid: 3719656
Dardé ML (2008) Toxoplasma gondii, “new” genotypes and virulence. Parasite Paris Fr 15:366–371. https://doi.org/10.1051/parasite/2008153366
doi: 10.1051/parasite/2008153366
de Oliveira Azevedo CT, do Brasil PEAA, Guida L, Lopes Moreira ME (2016) Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis. PLoS One 11:e0149938. https://doi.org/10.1371/journal.pone.0149938
doi: 10.1371/journal.pone.0149938 pubmed: 27055272 pmcid: 4824461
Demar M, Ajzenberg D, Maubon D, Djossou F, Panchoe D, Punwasi W, Valery N, Peneau C, Daigre J-L, Aznar C, Cottrelle B, Terzan L, Dardé M-L, Carme B (2007) Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin Infect Dis Off Publ Infect Dis Soc Am 45:e88–e95. https://doi.org/10.1086/521246
doi: 10.1086/521246
Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, Louvel D, Bourbigot A-M, Nasser V, Ajzenberg D, Darde M-L, Carme B (2012) Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18:E221–E231. https://doi.org/10.1111/j.1469-0691.2011.03648.x
doi: 10.1111/j.1469-0691.2011.03648.x
Djurković-Djaković O, Djokić V, Vujanić M, Zivković T, Bobić B, Nikolić A, Slavić K, Klun I, Ivović V (2012) Kinetics of parasite burdens in blood and tissues during murine toxoplasmosis. Exp Parasitol 131:372–376. https://doi.org/10.1016/j.exppara.2012.05.006
doi: 10.1016/j.exppara.2012.05.006 pubmed: 22613495
Edvinsson B, Jalal S, Nord CE, Pedersen SB, Evengard B, ECSMID Study Group on Toxoplasmosis (2004) DNA extraction and PCR assays for detection of Toxoplasma gondii. APMIS Acta Pathol Microbiol Immunol Scand 112:342–348. https://doi.org/10.1111/j.1600-0463.2004.apm1120604.x
Kompalic-Cristo A, Frotta C, Suárez-Mutis M, Fernandes O, Britto C (2007) Evaluation of a real-time PCR assay based on the repetitive B1 gene for the detection of Toxoplasma gondii in human peripheral blood. Parasitol Res 101:619–625. https://doi.org/10.1007/s00436-007-0524-9
doi: 10.1007/s00436-007-0524-9 pubmed: 17385062
Leal FE, Cavazzana CL, de Andrade HF, Galisteo AJ, Mendonça JS, Kallas EG (2007) Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis Off Publ Infect Dis Soc Am 44:e62–e66. https://doi.org/10.1086/511871
doi: 10.1086/511871
Lévêque MF, Chiffré D, Galtier C, Albaba S, Ravel C, Lachaud L, Iemmi A, Flori P, Sterkers Y (2019) Molecular diagnosis of toxoplasmosis at the onset of symptomatic primary infection: a straightforward alternative to serological examinations. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 79:131–133. https://doi.org/10.1016/j.ijid.2018.11.368
doi: 10.1016/j.ijid.2018.11.368
Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35:174–178
doi: 10.1128/JCM.35.1.174-178.1997
Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS (2001) Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 183:1248–1253. https://doi.org/10.1086/319672
doi: 10.1086/319672 pubmed: 11262207
Marín JEG, Zuluaga JD, Campo EJP, Triviño J, de-la Torre A (2018) Polymerase chain reaction (PCR) in ocular and ganglionar toxoplasmosis and the effect of therapeutics for prevention of ocular involvement in South American setting. Acta Trop 184:83–87. https://doi.org/10.1016/j.actatropica.2018.01.013
doi: 10.1016/j.actatropica.2018.01.013
Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R, Schumacher U, Pautas C, Theunissen K, Schindel C, Muñoz C, Margall N, Cordonnier C, Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation (2005) Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am 40:67–78. https://doi.org/10.1086/426447
doi: 10.1086/426447
Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976. https://doi.org/10.1016/S0140-6736(04)16412-X
doi: 10.1016/S0140-6736(04)16412-X pubmed: 15194258
Neves ES, Bicudo LN, Curi AL, Carregal E, Bueno WF, Ferreira RG, Amendoeira MR, Benchimol E, Fernandes O (2009) Acute acquired toxoplasmosis: clinical-laboratorial aspects and ophthalmologic evaluation in a cohort of immunocompetent patients. Mem Inst Oswaldo Cruz 104:393–396. https://doi.org/10.1590/s0074-02762009000200039
doi: 10.1590/s0074-02762009000200039 pubmed: 19430671
Neves ES, Kropf A, Bueno WF, Bonna ICF, Curi ALL, Amendoeira MRR, Fernandes O (2011) Disseminated toxoplasmosis: an atypical presentation in an immunocompetent patient. Trop Dr 41:59–60. https://doi.org/10.1258/td.2010.100228
doi: 10.1258/td.2010.100228
Patrat-Delon S, Gangneux J-P, Lavoué S, Lelong B, Guiguen C, Tulzo Y, Robert-Gangneux F (2010) Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J Clin Microbiol 48:2541–2545. https://doi.org/10.1128/JCM.00252-10
doi: 10.1128/JCM.00252-10 pubmed: 20463167 pmcid: 2897503
Santos FF, Nascimento H, Muccioli C, Costa DF, Rizzo LV, Commodaro AG, Belfort R (2015) Detection of Toxoplasma gondii DNA in peripheral blood and aqueous humor of patients with Toxoplasmic active focal necrotizing retinochoroiditis using real-time PCR. Arq Bras Oftalmol 78:356–358. https://doi.org/10.5935/0004-2749.20150094
doi: 10.5935/0004-2749.20150094 pubmed: 26677037
Silveira C, Vallochi AL, Silva UR, Muccioli C, Holland GN, Nussenblatt RB, Belfort R, Rizzo LV (2011) Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 95:396–400. https://doi.org/10.1136/bjo.2008.148205
doi: 10.1136/bjo.2008.148205 pubmed: 20601663
Xiao J, Yolken RH (2015) Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases. Acta Physiol Oxf Engl 213:828–845. https://doi.org/10.1111/apha.12458
doi: 10.1111/apha.12458

Auteurs

Elizabeth Souza Neves (ES)

Laboratório de Parasitologia, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil. elizabeth.neves@ini.fiocruz.br.

Otavio Melo Espíndola (OM)

Laboratório de Pesquisa Clínica em Neuroinfecções, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil. otavio.espindola@ini.fiocruz.br.

André Curi (A)

Laboratório de Oftalmologia, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.

Maria Regina Amendoeira (MR)

Laboratório de Toxoplasmose, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.

Danielle Nascimento Rocha (DN)

Laboratório de Alta Complexidade, Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, Brazil.

Leonardo Henrique Ferreira Gomes (LHF)

Laboratório de Alta Complexidade, Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, Brazil.

Letícia Cunha Guida (LC)

Laboratório de Alta Complexidade, Instituto Fernandes Figueira, Fiocruz, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH